Differential expression of HOX genes in neoplastic and non-neoplastic human astrocytes
- PMID: 16463268
- DOI: 10.1002/path.1939
Differential expression of HOX genes in neoplastic and non-neoplastic human astrocytes
Abstract
HOX genes are a large family of regulatory genes implicated in the control of developmental processes. HOX genes are involved in malignant transformation and progression of different types of tumour. Despite intensive efforts to delineate the expression profiles of HOX genes in other cell types, nothing is known regarding the global expression profile of these genes in normal human astrocytes and astrocytomas. The present study has analysed the expression profile of the 39 class I HOX genes in normal human astrocytes (NHA and E6/E7), two well-established glioblastoma cell lines (U-87 MG and U-1242-MG), as well as neoplastic (WHO grades II/III and IV) and non-neoplastic temporal lobe specimens with hippocampal sclerosis and medically intractable epilepsy. RT-PCR, quantitative real-time PCR, immunocytochemistry, and western blot analyses revealed differential expression of nine HOX genes (A6, A7, A9, A13, B13, D4, D9, D10, and D13) in normal human astrocytic cell lines and non-neoplastic temporal lobe specimens. The data show that HOX genes are differentially expressed in neoplastic and non-neoplastic astrocytes and that multiple HOX genes are overexpressed in glioblastoma cell lines, astrocytomas (II/III), and glioblastoma multiforme. The differential expression of HOX genes in normal and neoplastic astrocytes suggests a role for these genes in brain tumourigenesis.
Copyright 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
-
Aberrant expression of HOX genes in human invasive breast carcinoma.Oncol Rep. 2005 Apr;13(4):673-9. Oncol Rep. 2005. PMID: 15756441
-
Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.Glia. 2003 Apr 15;42(2):194-208. doi: 10.1002/glia.10222. Glia. 2003. PMID: 12655603
-
Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.Oncogene. 2006 May 4;25(19):2818-26. doi: 10.1038/sj.onc.1209305. Oncogene. 2006. PMID: 16314830
-
HOX genes in human cancers.Invasion Metastasis. 1994-1995;14(1-6):38-49. Invasion Metastasis. 1994. PMID: 7657531 Review.
-
[Homeoproteins: participation in hematopoietic processes?].Nouv Rev Fr Hematol (1978). 1993 Jun;35(3):275-7. Nouv Rev Fr Hematol (1978). 1993. PMID: 8101652 Review. French.
Cited by
-
HOX gene cluster (de)regulation in brain: from neurodevelopment to malignant glial tumours.Cell Mol Life Sci. 2020 Oct;77(19):3797-3821. doi: 10.1007/s00018-020-03508-9. Epub 2020 Apr 1. Cell Mol Life Sci. 2020. PMID: 32239260 Free PMC article. Review.
-
Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models.Genom Data. 2015 May 19;5:54-8. doi: 10.1016/j.gdata.2015.05.010. eCollection 2015 Sep. Genom Data. 2015. PMID: 26484224 Free PMC article.
-
HOXA5 Is Recognized as a Prognostic-Related Biomarker and Promotes Glioma Progression Through Affecting Cell Cycle.Front Oncol. 2021 Aug 17;11:633430. doi: 10.3389/fonc.2021.633430. eCollection 2021. Front Oncol. 2021. PMID: 34485110 Free PMC article.
-
Molecular prognostic factors in glioblastoma: state of the art and future challenges.CNS Oncol. 2013 Nov;2(6):495-510. doi: 10.2217/cns.13.48. CNS Oncol. 2013. PMID: 25054820 Free PMC article. Review.
-
Knockdown of lncRNA HOXD-AS2 Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells.Evid Based Complement Alternat Med. 2022 Nov 9;2022:9337647. doi: 10.1155/2022/9337647. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Jul 19;2023:9859158. doi: 10.1155/2023/9859158. PMID: 36408341 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources